PGA Tour suspends Trey Mullinax for anti-doping violation

Professional golfer Trey Mullinax is serving a six-month suspension from the PGA Tour. The decision follows a positive test for a performance-enhancing substance that violated the tour's anti-doping policy.

Mullinax, 34, admitted to using medication for a condition he was diagnosed with during his college years. He failed to seek the necessary approval from the tour before taking the treatment. Because the substance is prohibited under the current rules, the suspension is mandatory.

In a statement, Mullinax accepted full responsibility for the oversight. He noted that while he never intended to gain a competitive advantage, he recognizes that his failure to understand and follow the anti-doping regulations is a personal error. He stated that he respects the game and intends to return to competition on January 16, 2027.

This case marks another instance where a golfer has faced disciplinary action under the policy that began in 2008. The tour requires players to maintain compliance with all medical declarations to ensure fair play across all events. Mullinax is cooperating with officials as he serves his suspension.